GlassScriptPhysician profile
Douglas C Miller
NPI 1952441446
$16,294.53
in general payments reported to CMS, 2019-2025
30 companies · $1,617 in 2025
The $1,617 reported for 2025 was more than what 79% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,504 · 2020: $226 · 2021: $376 · 2022: $10K · 2023: $2,129 · 2024: $340 · 2025: $1,617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,158 · Education: $1,000 · Travel and Lodging: $928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,158.33 |
| Education | $1,000.00 |
| Travel and Lodging | $928.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,693.77 | 2021-2023 | Davinci Xi, Da Vinci Surgical System |
| Endologix LLC | $3,228.78 | 2019-2025 | Alto Abdominal Stent Graft System, Afx2 Bifurcated Endograft System, Ovation Ix Iliac Stent Graft |
| Boston Scientific Corporation | $2,580.80 | 2021-2025 | Ekosonic, Varithena Administration Pack, Jetstream Sc |
| C. R. Bard, INC. & Subsidiaries | $464.50 | 2019 | |
| Davol INC. | $373.76 | 2019-2025 | Phasix Mesh |
| Medtronic, INC. | $202.53 | 2021-2025 | Venaseal, Hawkone, Transorb |
| Bard Peripheral Vascular, INC. | $160.21 | 2022-2025 | Venclose Maven Catheter |
| Enterra Medical, INC. | $70.02 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $51.11 | 2024-2025 | |
| Inari Medical, INC. | $48.00 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Hologic INC | $47.36 | 2021 | |
| Medtronic Vascular, INC. | $46.94 | 2019 | |
| Redhill Biopharma INC. | $27.83 | 2020-2021 | |
| Abbvie INC. | $27.55 | 2024 | |
| Myriad Genetic Laboratories, INC. | $25.42 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $21.73 | 2019 | |
| Chiesi USA, INC. | $21.64 | 2019 | |
| Surmodics, INC. | $21.49 | 2023 | Sublime Radial Access 018 Rx Pta Dilatation Catheter, Pounce Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Alexion Pharmaceuticals, INC. | $20.97 | 2022 | |
| Ferring Pharmaceuticals INC. | $20.37 | 2022 | |
| Heron Therapeutics, INC. | $18.92 | 2022 | |
| Shockwave Medical, INC | $18.77 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.75 | 2024 | Exparel |
| Cook Medical LLC | $15.49 | 2019 | |
| Innocoll Pharmaceuticals Limited | $15.46 | 2022 | |
| Terumo Medical Corporation | $13.59 | 2023 | Angio-Seal |
| W. L. Gore & Associates, INC. | $11.74 | 2019 | |
| Merck Sharp & Dohme LLC | $10.86 | 2019 | |
| Janssen Pharmaceuticals, INC | $10.81 | 2019 | |
| Kerecis Limited | $6.36 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.